FDA Clearance Tracker · K152353
SeraQuest HSV Type 2 Specific IgG
Last checked: Nov 20, 2026Latest source record: May 13, 2016 (this decision)Source: openFDAMethods & limitations
Decided
May 13, 2016
Substantially Equivalent
Time to decision
267 days
Received Aug 20, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K152353
- Device name
- SeraQuest HSV Type 2 Specific IgG
- Applicant
- Quest International, Inc.
- Applicant location
- Mami, FL
- Received
- Aug 20, 2015
- Decided
- May 13, 2016
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.3305
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MYF. The earliest in FDA's data is K993724, decided Feb 1, 2000.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K152353
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Quest International, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K181514 · Decided Jun 13, 2019 · 370 days after receipt
Device type: Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2 (MYF) · Laboratory Medicine & Pathology
K162276 · Decided Oct 1, 2016 · 50 days after receipt
Device type: Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-1 (MXJ) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.